Mostrar el registro sencillo del ítem

Angiogenic T cells: potential biomarkers for the early diagnosis of interstitial lung disease in autoimmune diseases?

dc.contributor.authorPulito Cueto, V.
dc.contributor.authorRemuzgo Martínez, S.
dc.contributor.authorGenre, F.
dc.contributor.authorAtienza Mateo, B.
dc.contributor.authorMora Cuesta, V. M.
dc.contributor.authorIturbe Fernández, D.
dc.contributor.authorLera Gómez, L.
dc.contributor.authorRodríguez Carrio, Javier 
dc.date.accessioned2022-11-08T12:42:44Z
dc.date.available2022-11-08T12:42:44Z
dc.date.issued2022
dc.identifier.citationBiomedicines, 10(4) (2022); doi:10.3390/biomedicines10040851
dc.identifier.issn2227-9059
dc.identifier.urihttp://hdl.handle.net/10651/65360
dc.description.sponsorshipV.P.-C. and S.R.-M. are supported by funds of RETICS Program [RD16/0012/0009, Instituto de Salud Carlos III (ISCIII), co-funded by European Regional Development Fund (ERDF); FG is supported by funds of the RICORS Program (RD21/0002/0025) from ISCIII, co-funded by the European Union; OG is staff personnel of Xunta de Galicia (Servizo Galego de Saude (SERGAS) through a research-staff stabilization contract (ISCIII/SERGAS) and his work is funded by ISCIII and ERDF [RD16/0012/0014 (RIER) and PI17/00409]. He is the beneficiary of project funds from the Research Executive Agency of the European Union in the framework of MSCA-RISE Action of the H2020 Programme, project 734899—Olive-Net. RL-M is a recipient of a Miguel Servet type II Program fellowship from ISCIII, co-funded by the European Social Fund, ‘Investing in your future’ (CPII21/00004).
dc.description.statementofresponsibilityPulito-Cueto V, Remuzgo-Martínez S, Genre F, Atienza-Mateo B, Mora-Cuesta VM, Iturbe-Fernández D, Lera-Gómez L, Rodriguez-Carrio J, Prieto-Peña D, Portilla V, Blanco R, Corrales A, Gualillo O, Cifrián JM, López-Mejías R, González-Gay MA
dc.language.isoeng
dc.relation.ispartofBiomedicines
dc.rights© 2022 Los autores
dc.rightsCC Reconocimiento 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScopus
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85128474728&doi=10.3390%2fbiomedicines10040851&partnerID=40&md5=df8d29e3c387f32eabd0ae5c5b333818
dc.titleAngiogenic T cells: potential biomarkers for the early diagnosis of interstitial lung disease in autoimmune diseases?
dc.typejournal article
dc.identifier.doi10.3390/biomedicines10040851
dc.relation.projectIDISCIII/ERDF/RD16/0012/0009
dc.relation.projectIDISCIII/ERDF/RD21/0002/0025
dc.relation.projectIDISCIII/ERDF/RD16/0012/0014
dc.relation.projectIDISCIII/ERDFPI17/00409
dc.relation.projectIDinfo:eu‐repo/grantAgreement/EC/H2020/734899
dc.relation.publisherversionhttp://dx.doi.org/10.3390/biomedicines10040851
dc.rights.accessRightsopen access
dc.type.hasVersionVoR


Ficheros en el ítem

untranslated

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

© 2022 Los autores
Este ítem está sujeto a una licencia Creative Commons